SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

DMCC Speciality Chemicals board approves dividend

05 May 2025 Evaluate
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 (‘Listing Regulations’), DMCC Speciality Chemicals has informed that the Board of Directors of the Company at its meeting held today i.e. on Monday, May 05, 2025 Considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025, and they are enclosing: a) Audited Standalone & Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025; b) Declaration of Audit Report with Unmodified Opinion. Pursuant to Regulation 33(3)(d) of the Listing Regulations, we hereby declare that the Statutory Auditors of the Company, have issued Audit Reports with unmodified opinion on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2025; Recommended Final Dividend of 25% (Rs 2.50 per equity share of Rs 10 each) for the Financial Year ended March 31, 2025, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. The said dividend, if declared at the ensuing Annual General Meeting (AGM), will be paid to the shareholders within 30 days of AGM of the Company. 

The above information is a part of company’s filings submitted to BSE.

DMCC Speciality Chem Share Price

268.60 44.75 (19.99%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3572.40
Tata Chemicals 718.85
SRF 2445.05
Pidilite Inds. 1326.40
Deepak Nitrite 1475.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×